NK

Narendra Kumar Agarwal

Active Director Director DIN 10171575
DIN 10171575 First appointment Jun 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Narendra Kumar Agarwal

Data last updated:

Narendra Kumar Agarwal is a Director at Eleos Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Eleos Pharmaceuticals Private Limited reported revenue of ₹3 Lakh (FY 2025).

DIN 10171575
Primary Designation Director
Industry Chemicals
First Appointment 01 Jun 2023
Oldest Company Age 8 yrs
Largest company Eleos Pharmaceuticals Private Limited · ₹3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20232018₹3 Lakh (FY 2025)Active

Board colleagues of Narendra Kumar Agarwal

Directorship timeline

Open interactive timeline →
Eleos Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Narendra Kumar Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narendra Kumar Agarwal

Narendra Kumar Agarwal currently holds 1 directorship: Eleos Pharmaceuticals Private Limited (Director, since 01 Jun 2023, revenue ₹3 Lakh (FY 2025)).

Narendra Kumar Agarwal was first appointed on 01 Jun 2023 as Director at Eleos Pharmaceuticals Private Limited.

The current boards of Narendra Kumar Agarwal's companies include Nikhil Agarwal (Eleos Pharmaceuticals Private Limited), Wahid (Eleos Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available